Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Jackpot Digital (TSXV:JJ): Meet the company revolutionizing casino gaming

What does the future of casino gaming look like? Well, just imagine, for a moment, being on a cruise, playing the tables at the casino, and you hit a patch of rough waters. Well, Jackpot Digital, it seems, has thought of this. They signed a deal in 2017 with Carni...

Finding the Jackpot in the Electronic Gaming Machine Market

I have an interest in gambling and poker as a venue for some modest entertainment. After all, investing in penny stocks would qualify as gambling, but like any gambler, we look for an edge or advantage. With penny stocks, my edge is many years of experience and a long lis...

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer...

Akcea Therapeutics Inks Worldwide Licensing Deal with Pfizer for Investigative Antisense Therapy, Shares Up 30% Akcea Therapeutics' shares are trading 30% higher today on news that it has entered into a worldwide exclusive licensing agreement with Pfizer for AKCEA-ANG...

Pulmatrix's Licensing Deal with the JNJ Lung Cancer Initiative Sends Shares Up 100%

Pulmatrix's shares opened 90% higher today after the firm reported that it has signed a kinase inhibitor licensing agreement with the Lung Cancer Initiative at Johnson & Johnson. Prior to the U.S. markets open this morning on the first day of trading in 2020, clinical...

Galapagos Agrees to $3.95 Billion, 10-Year Licensing Deal Plus $1.1 Billion Investment from Gilead

Galapagos announced that Gilead Sciences has agreed to pay $3.95 billion for a 10-year partnership and licensing deal and will invest an additional $1.1 billion in newly issued shares of the company. Galapagos NV (GLPG:NASDAQ; GLPG:BSE) ADR shares opened up over 1...

Gaming stocks that are worth tracking

Gaming has evolved from a pastime activity to become a career for some people and an educational tool for others. Gaming has produced some of the biggest global companies, such as Sony, Meta, Microsoft, and Tencent Holdings. How did companies like Microsoft and Meta get a...

Biopharma Makes Licensing Deal for Therapeutic Rights in Japan

The company's reasons for the transaction and expected short-term, stock-moving events are provided in a ROTH Capital Partners report. In a Sept. 9 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Eidos Therapeutics Inc. (EIDX:NASDAQ) agreed...

Growth ahead for online betting and sports markets

The online betting and sports markets are on the cusp of exceptional growth in Canada. Ontario is the first province to legalize traditional sports betting and NorthStar Gaming (TSXV:BET) is well-positioned for expansion. NorthStar owns and operates a casino and spo...

Get Lucky! Meet the Premier Esports Betting Platform. For Gamers, By Gamers

(CLICK IMAGE TO PLAY VIDEO) The online e-gaming industry is no longer just a phenomenon, it’s now globally omnipresent and is expected to reach $257 billion dollars in revenue by 2025. In fact, There are more than 2.7 billion video gamers around ...

California-Based Biopharma Signs Licensing Deal for Acquired Asset

The transaction details and the drug platform's potential are addressed in an H.C. Wainwright & Co. report. In May 21 research note, H.C. Wainwright & Co. analyst Joseph Pantginis reported that Ligand Pharmaceuticals Inc. (LGND:NASDAQ) signed a licensing d...
1 2 3 4 5 6 7 8 9 10 ...